Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Title:Subject Index To Volume 1
Volume: 2 Issue: 1
Author(s): Science Publishers Bentham and Bentham Science Publishers
Affiliation:
Export Options
About this article
Cite this article as:
Bentham Publishers Science and Bentham Science Publishers , Subject Index To Volume 1, Current Drug Targets - Immune, Endocrine & Metabolic Disorders 2002; 2 (1) . https://dx.doi.org/10.2174/1568008024606275
DOI https://dx.doi.org/10.2174/1568008024606275 |
Print ISSN 1568-0088 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5917 |
8
Related Articles
-
Hashimotos Thyroiditis: From Genes to the Disease
Current Genomics Alkaloids as Important Scaffolds in Therapeutic Drugs for the Treatments of Cancer, Tuberculosis, and Smoking Cessation
Current Topics in Medicinal Chemistry Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents
Current Cancer Drug Targets Metabolic Control of Type 2 Diabetes by Targeting the GLUT4 Glucose Transporter: Intervention Approaches
Current Pharmaceutical Design The Modulation of Inter-Organelle Cross-Talk to Control Apoptosis
Medicinal Chemistry Preclinical Evaluation of In-111 and Ga-68 Labelled Minigastrin Analogues for CCK-2 Receptor Imaging
Current Radiopharmaceuticals Beneficiary and Adverse Effects of Phytoestrogens: A Potential Constituent of Plant-based Diet
Current Pharmaceutical Design Anti-inflammatory Phytochemicals for Chemoprevention of Colon Cancer
Current Cancer Drug Targets The Potential of Peroxisome Proliferator-Activated Receptor γ (PPARγ) Ligands in the Treatment of Hematological Malignancies
Mini-Reviews in Medicinal Chemistry Colloidal Polymeric Nanoparticles and Brain Drug Delivery
Current Drug Delivery Mitochondrial Membrane Lipids in Life and Death and their Molecular Modulation by Diet: Tuning the Furnace
Current Drug Targets Pharmacogenomics of Xenobiotic Metabolizing Enzymes in South American Populations
Current Pharmacogenomics Pharmaceutical Interventions for Frailty and Sarcopenia
Current Pharmaceutical Design Targetability of Human Disease Genes
Current Drug Discovery Technologies Drug-induced Cholelithiasis
Current Reviews in Clinical and Experimental Pharmacology Recent Advances in the Research and Development of B-Raf Inhibitors
Current Medicinal Chemistry Acyl Thiourea Derivatives Containing Pyrazole Ring Selective Targeting of Human Aurora Kinases in Breast and Bone Cancer
Letters in Drug Design & Discovery Labeling Polyamidoamine (PAMAM) Dendrimers with Technetium-99m via Hydrazinonicotinamide (HYNIC)
Current Radiopharmaceuticals Remote Preconditioning- Endocrine Factors in Organ Protection Against Ischemic Injury
Endocrine, Metabolic & Immune Disorders - Drug Targets Drug Interactions with Normal and TEN Epidermal Keratinocytes
Current Drug Safety